Who is Singulair® Tablets approved for?
Singulair® Tablets is approved for the long-term prevention and control of asthma in both adults and children, with specific strengths used depending on age. It may also be prescribed for exercise-related breathing symptoms and certain allergies, but asthma management remains a key use.
- Approved for asthma in patients 12 months and older
- 10 mg tablets typically used in ages 15+
- 5 mg chewable tablets used in children 6-14
- May be part of a broader asthma treatment plan
- “30 tablets” refers to package quantity, not treatment duration
Your provider will select the right strength and form based on age and medical needs.





